# Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction

> **NCT02579772** · PHASE4 · COMPLETED · sponsor: **Queen's University** · enrollment: 13 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** N-acetylcysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02579772
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02579772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02579772, "Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02579772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*